Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment-Reference-Cited by-同舟云学术

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro Cytochrome P450 Induction Studies Including Impact on Drug Interaction Risk Assessment

Published:2020-11-02 Issue:1 Volume:49 Page:94-110
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Wong Simon G.,Ramsden Diane^ORCID,Dallas Shannon,Fung Conrad,Einolf Heidi J.,Palamanda Jairam^ORCID,Chen Liangfu,Goosen Theunis C.,Siu Y. Amy,Zhang George,Tweedie Donald,Hariparsad Niresh,Jones Barry,Yates Phillip D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference39 articles.

1. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

2. The relative performance of AIC, AICC and BIC in the presence of unobserved heterogeneity;Brewer;Methods Ecol Evol,2016

3. Burnham KP Anderson DR (2002) Model Selection and Multimodel Inference, Springer-Verlag, New York.

4. In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective

5. Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes;Drocourt;Drug Metab Dispos,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic;Drug Metabolism Reviews;2024-07-26

2. Physiologically Based Pharmacokinetic Modeling of the Drug–Drug Interaction Between CYP3A4 Substrate Glasdegib and Moderate CYP3A4 Inducers in Lieu of a Clinical Study;The Journal of Clinical Pharmacology;2023-10-18

3. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

4. Cytochrome P450 1A2 and 2C enzymes autoinduced by omeprazole in dog hepatocytes and human HepaRG and HepaSH cells are involved in omeprazole 5-hydroxylation and sulfoxidation;Xenobiotica;2023-07-03

5. Stability Characterization of the Novel Anti-Cancer HM-10/10 HDL-Mimetic Peptide;International Journal of Molecular Sciences;2023-06-13